# Major Recall Alert: Neupogen 300 mcg/mL (480 mcg /1.6 mL) Vials Recalled Due to Stability Issues
Consumers and healthcare providers should be aware of a significant recall involving **Neupogen 300 mcg/mL (480 mcg /1.6 mL) vials**, distributed by **Amgen Canada**. The recall has been issued because the stability of the product may be **out of specification in the affected lots**, posing potential safety risks. Below, we provide detailed information on this recall and actionable steps to ensure your safety.
---
## Why This Recall is Important
Neupogen, a medication often prescribed to boost white blood cell counts in individuals undergoing treatments like chemotherapy, plays a critical role in immune health. Medications with compromised stability may lose effectiveness before their expiry date or produce undesired side effects, potentially jeopardizing patient well-being.
This recall highlights the need for vigilance when it comes to the integrity of critical medications. Ensuring proper stability and potency is crucial to maintaining the safety and efficacy of treatments, particularly for those with compromised immune systems.
---
## Details of the Recall
Here’s what you need to know about the Neupogen recall:
- **Product Name**: Neupogen 300 mcg/mL (480 mcg /1.6 mL) vials
- **Category**: Medication
- **Manufacturer/Distributor**: Amgen Canada
- **Reason for Recall**: The stability of the product may be **out of specification** in certain lots.
- **Date Announced**: Noted as October 28, 2023
- **Official Recall Source**: [Government of Canada Recall Notice](https://recalls-rappels.canada.ca/en/alert-recall/neupogen-vials-out-specification-stability)
If you or someone in your care currently uses Neupogen, it’s essential to determine if your vials are part of the affected lots and take appropriate action to protect your health.
---
## What You Should Do
If you are concerned about this recall, follow these steps to stay protected:
- **Check Your Medication**: Review the lot number on the packaging of your Neupogen vials to determine if they are part of the recall. You can cross-reference this information with the official recall notice [here](https://recalls-rappels.canada.ca/en/alert-recall/neupogen-vials-out-specification-stability).
- **Contact Your Healthcare Provider**: Stop using the medication if you have any doubts about its safety. Immediately reach out to your prescribing physician, pharmacist, or healthcare provider for alternative treatments or replacements.
- **Report Adverse Reactions**: If you notice any side effects or issues while using this product, report them directly to Health Canada. Filing a report helps ensure swift action and transparency for future recalls.
For additional guidance, contact the customer service department at Amgen Canada for assistance. Keep records of your purchase and medication for any future reference.
---
## Stay Safe – Get Instant Recall Alerts
Protecting yourself and your loved ones from potential health risks requires staying informed. Download the **MyRecalls App** today to receive **instant notifications about product recalls, safety alerts, and more**. With this easy-to-use platform, you can quickly identify potentially dangerous products – including medications like Neupogen – and take timely action.
[**Download the MyRecalls App Now**](https://myrecalls.app) to safeguard your health and never miss an important update.
---
By acting promptly, you can help prevent harmful outcomes and ensure that you are using safe, stable medications. For further information, visit the official **Government of Canada Recall Notice** [here](https://recalls-rappels.canada.ca/en/alert-recall/neupogen-vials-out-specification-stability) and stay proactive.
Stay informed, stay safe, and share this information with anyone who may need it!